These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14266590)

  • 1. [WILSON'S DISEASE IN THE FORM OF A PANHEMOCYTOPENIA].
    HEINRICH F; KALTENBACH M
    Med Klin; 1965 Mar; 60():499-502. PubMed ID: 14266590
    [No Abstract]   [Full Text] [Related]  

  • 2. BASAL COPPER EXCRETION IN WILSON'S DISEASE.
    WARREN CB; BROUGHTON PM
    Arch Dis Child; 1964 Jun; 39(205):265-7. PubMed ID: 14169457
    [No Abstract]   [Full Text] [Related]  

  • 3. HEPATO-LENTICULAR DEGENERATION (WILSON'S DISEASE) TREATED BY PENICILLAMINE.
    RICHMOND J; ROSENOER VM; TOMPSETT SL; DRAPER I; SIMPSON JA
    Brain; 1964 Dec; 87():619-38. PubMed ID: 14236007
    [No Abstract]   [Full Text] [Related]  

  • 4. WILSON'S DISEASE PRESENTING AS AN ACUTE HAEMOLYTIC ANAEMIA.
    LAURANCE BM
    Proc R Soc Med; 1965 Aug; 58(8):614-5. PubMed ID: 14341840
    [No Abstract]   [Full Text] [Related]  

  • 5. COPPER BALANCE STUDIES IN WILSON'S DISEASE; OBSERVATIONS ON THE EFFECT OF PENICILLAMINE, CARBACRYLAMINE RESINS, AND POTASSIUM SULFIDE.
    GOLDSTEIN NP; RANDALL RV; GROSS JB; MCGUCKIN WF
    Arch Neurol; 1965 May; 12():456-62. PubMed ID: 14288982
    [No Abstract]   [Full Text] [Related]  

  • 6. TREATMENT OF HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE) IN THE ASYMPTOMATIC STAGE.
    TU JB; COOPER WC; BLACKWELL RQ; HOU TY
    Neurology; 1965 Apr; 15():402-8. PubMed ID: 14280605
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemorrhagic diathesis in Wilson's disease. Plasmatic or thrombocytic etiology?].
    Sutor AH; Ketelsen UP
    Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):386-8. PubMed ID: 4751469
    [No Abstract]   [Full Text] [Related]  

  • 8. Hematologic (cytopenic) manifestations of Wilson's disease (hepatolenticular degeneration).
    Hogland HC; Goldstein NP
    Mayo Clin Proc; 1978 Aug; 53(8):498-500. PubMed ID: 682676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of some clotting factors in hepatolenticular degeneration (Wilson's disease).
    Procházka J; Hauftová D
    Gastroenterologia; 1965; 104(6):325-34. PubMed ID: 5857077
    [No Abstract]   [Full Text] [Related]  

  • 11. COPPER BALANCE STUDIES IN WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION). OBSERVATIONS ON THE EFFECT OF PENICILLAMINE, CARBO-RESIN AND POTASSIUM SULFIDE.
    GOLDSTEIN NP; RANDALL RV; GROSS JB; MCGUCKIN WF
    Trans Am Neurol Assoc; 1963; 88():221-2. PubMed ID: 14272232
    [No Abstract]   [Full Text] [Related]  

  • 12. THE NEPHROTIC SYNDROME AS A COMPLICATION OF PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE).
    HIRSCHMAN SZ; ISSELBACHER KJ
    Ann Intern Med; 1965 Jun; 62():1297-300. PubMed ID: 14295512
    [No Abstract]   [Full Text] [Related]  

  • 13. COPPER BALANCE STUDIES DURING THE TREATMENT OF PATIENTS WITH WILSON'S DISEASE.
    TU JB; BLACKWELL RQ; WATTEN RH
    Metabolism; 1965 Jun; 14():653-66. PubMed ID: 14293521
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of penicillamine therapy and low-copper diet on dysarthria in Wilson's disease (hepatolenticular degeneration).
    Berry WR; Aronson AE; Darley FL; Goldstein NP
    Mayo Clin Proc; 1974 Jun; 49(6):405-8. PubMed ID: 4835812
    [No Abstract]   [Full Text] [Related]  

  • 15. ENDOGENOUS COPPER CLEARANCE IN WILSON'S DISEASE: A STUDY OF THE MODE OF ACTION OF PENICILLAMINE.
    WALSHE JM
    Clin Sci; 1964 Jun; 26():461-9. PubMed ID: 14191274
    [No Abstract]   [Full Text] [Related]  

  • 16. [WILSON'S DISEASE AND ITS TREATMENT].
    JANSEN EG; BEN-GERSHOM E
    Ned Tijdschr Geneeskd; 1964 Sep; 108():1834-5. PubMed ID: 14226649
    [No Abstract]   [Full Text] [Related]  

  • 17. [OUR EXPERIENCE IN THE TREATMENT OF WILSON'S DISEASE WITH PENICILLAMINE].
    BOUDIN G; PEPIN B; LAURAS A; BARRAINE R
    Rev Neurol (Paris); 1963 Jul; 109():82-6. PubMed ID: 14091678
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
    Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ocular manifestations of Wilson's disease treated by penicillamine].
    MICHIELS J; LATERRE C; DUMOULIN D
    Bull Soc Belge Ophtalmol; 1963; 132():552-61. PubMed ID: 13935542
    [No Abstract]   [Full Text] [Related]  

  • 20. [WILSON'S DISEASE TREATED BY PENICILLAMINE].
    BERNHEIM M; FREYCON MT; PELLET H; DEFFRENNE P; LAMIT J
    Pediatrie; 1964; 19():373-5. PubMed ID: 14147228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.